[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Renishaw Plc LSE:RSW London Ordinary Share GB0007323586 ORD 20P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  22.00 0.48% 4,604.00 4,596.00 4,616.00 4,612.00 4,578.00 4,612.00 423 08:09:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 565.6 139.4 153.2 30.1 3,352

Renishaw Share Discussion Threads

Showing 676 to 700 of 1250 messages
Chat Pages: Latest  38  37  36  35  34  33  32  31  30  29  28  27  Older
DateSubjectAuthorDiscuss
16/12/2013
08:10
www.playitback.org/details.aspx?v=336
apad
15/11/2013
15:09
Naaa! We used to store white metal bodies in plastic bags on Castle Bromwich aerodrome and then put a labourer to work with some emery paper to remove the rust before painting them. Didn't need any research to know that wasn't a good idea. I wonder if all this additive hype is driving the share price over the last few days? apad
apad
15/11/2013
08:48
The unfortunate thing about bmc, bl etc, was that they let the customers do the R&D
mw
14/11/2013
18:06
FT fixated on additive manufacturing. From medicine to jet engines. red I remember when BMC told us they weren't in the business of making cars, they were in the business of making money (about the same time as they sold off the Rover test track and I bought a house on it). Since then I have taken the view that money is a by-product of being the best at making: cars, aero engines, metrology instruments.... apad
apad
14/11/2013
15:31
R&D investment is a long term process. It also needs consistent support, through good times and bad. But I suppose as a former engineer, I would say that. Dr.Tubbs of Moneyweek is a big fan. Price Up 4.2% as I write. Metrology accounts for 82% of the R&D this last year, so their report says.
mw
14/11/2013
12:09
APAD Time will tell, but it will be a slow burner. In the meantime it will chew up a few millions a year on R&D. SP performing today! red
redartbmud
13/11/2013
07:43
red Not so sure. The BEGO link is interesting and whilst dental prosthetics are something of a craft industry at the moment there might be a business for the future here. The BEGO website is informative. I can't see the neuro applications as having potential. I see some PR value in the speculative applications as well as the possibility of unanticipated consequences. So, I guess I am less critical of the R&D spend. mw I thought order visibility to be about a month? I think that RSW are brilliant at using university research centres, funded by the taxpayer. 36 jobs on offer (30 last time I looked). I think there might be a special divvy with the CAD profits. No concern about loss of influence with the new owners. Possibly a little upside on the current price (2.4% yield, price to cash flow 14 cf PER 19) before the 5% rise on the week. Content to hold. apad
apad
12/11/2013
20:35
mw This is where the Non-Execs are not doing their job. red
redartbmud
12/11/2013
20:34
APAD Yes. I formed an opinion at the previous AGM, which hasn't changed. It will never be big enough to recover costs already spent. The market will not buy, or if they do it will be minimal. No chance with NHS dentists. mw Is a lot of current new R&D a toy for DMcM? red
redartbmud
12/11/2013
17:14
red did you form an opinion of the dental stuff from the AGM? apad
apad
12/11/2013
16:22
The other side of the R & D coin is the IP which is generated. I think industrial R & D is generally more focussed unlike academia. Without it you'd become a bit moribund. So generally a good thing. How else do you diversify your product range, other than by acquisition. From previous comments elsewhere, I thought current order visibility (for metrology) was no greater than 3 months - perhaps it's improved recently.
mw
07/11/2013
08:04
- and now their Delcam stake is cashed Cash sum equates to about 2.6% of Renishaw's market capitalisation - so not a major sum - but how does this deal skew Renishaw's working partnership with Delcam under Delcam's new ownership?
m.t.glass
06/11/2013
08:55
APAD I don't disagree with your comments, especially with regard to Delcam. My negativity stems from an inadequate board of directors and the loss of the SID, Bill Whiteley. In the current climate R&D is allowed free reign in areas that are unlikely to generate significant commercial return. It needs to be addressed - now. red
redartbmud
06/11/2013
08:27
I'm more sceptical on additive manufacturing. It is a slow process and the mechanical properties of the product are poor. I don't think I can accept a generic argument for the process - the argument needs to be couched in terms of a specific product class (or perhaps prototyping process). One can argue that it is appropriate for a tooling process, in that a shape can be made to act as a pattern for, say, casting. This is the area I would choose as a possibility (the involvement of Delcam gives some confidence in this area). There has been an awful lot of development and research funding in these processes for some 30 years now - all based on generic rather than specific potential. Having said all that I have enormous confidence of Renishaw and Delcam management, having met both over a number of years (disclaimer: I'm no longer involved with the technology). RSWW is my largest holding and I regret not holding Delcam (other then by proxy:-) apad
apad
28/10/2013
14:51
Red, Many thanks. Cellars
cellars
21/10/2013
07:18
cellars In answer to your question: Additive manufacturing could be commercially huge. To be commercial it needs;- 1. Process control. 2. Automation of how to handle the parts. Renishaw are working on the solutions. No suggestion of a timeframe. red
redartbmud
19/10/2013
08:53
Red Was there discussion at the AGM of additive mfg? Cellars
cellars
18/10/2013
14:21
RR They need to start by reorganizing the Board. FD to retire. New Non-exec Chairman. New Chief Exec. Clear out Non-exec directors and replace them with ones who have some drive. Review business strategy. Address cost structure. I could go on, but they are just not managing effectively or efficiently at present. The business is drifting in the breeze. red
redartbmud
18/10/2013
09:42
Just to clarify, I was only stating the facts. A one off order from Foxconn lead to an exceptional 1st quarter and the share price went ahead of itself - I sold out then and bought back in on the dip to £15 in April As to the prospects going forward, manufacturing is still continuing to recover in a stuttering fashion. There are good prospects for RSW to grow its metrology business at a healthy rate based on an excellent and in areas unique product offering, and 9% underlying is healthy. There are issues, it is not the leanest of companies, they need to get better control of finances, and Medical is a dissapointment and is a distraction from the core business.
rogerrail
18/10/2013
08:53
red so many warnings signs in all this you are right to sell in my view
chairman20
18/10/2013
07:16
Sorry to rain on the parade, but I have turned negative on the company. The presentation at the AGM was very downbeat compared to previous years, and the whole thing rambled on until I had lost the will to live. The Chairman stumbled his way through a multitude of errors in the process of conducting the meeting. Great feature was made on medical, probably 60% of the talk - BUT when questioned we were informed that in the neuro area there was no revenue and all costs are being written off anually as R&D as it was wholly experimental. I see the market as negligible going forward. The senior independent director, and the one with focus, Bill Whiteley has left. I can just imagine him wringing his hand in horror at board meetings. Whilst there are new developments in the core business, I see the comany as having lost focus on what are its business and markets. I will reduce my holdings in an orderly fashion from here.
redartbmud
17/10/2013
15:45
toched support today
bad robot
17/10/2013
11:18
RogerRail. I rather think you are missing the point, to say the 'underlying revenue increased 9%' they are ignoring the exceptional and one assumes the highly profitable orders from last year. These are drab results, I'm not surprised as the World economy is drab. The boost that has been derived from the China growth story now needs to be removed from future projections. This is not just Renishaw's problem but that of many others as the World goes ex-China growth.
chrisgail
17/10/2013
10:44
Comparison to Q2 more appropriate than to Q1, revenue Q2 last year £78M, profits £15M , Q1 this yr £79M Profits £10.6M. underlying revenue increased 9%, Drop in profits due to 5% increase in cost base to align the business to future demand.
rogerrail
17/10/2013
10:06
Profits in first quarter down more than 50%.
chrisgail
Chat Pages: Latest  38  37  36  35  34  33  32  31  30  29  28  27  Older
ADVFN Advertorial
Your Recent History
LSE
RSW
Renishaw
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211129 08:24:13